{"cik":1563190,"entityName":"Compass, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-05-10","val":393973089,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":36600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":39900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AccountsReceivableNetCurrent":{"label":"Accounts Receivable, after Allowance for Credit Loss, Current","description":"Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.","units":{"USD":[{"end":"2020-12-31","val":54800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":58300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AccruedSalesCommissionCurrent":{"label":"Accrued Sales Commission, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":62000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":55300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapitalCommonStock":{"label":"Additional Paid in Capital, Common Stock","description":"Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.","units":{"USD":[{"end":"2020-12-31","val":238000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":486000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition":{"label":"APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":11100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":165000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":11100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":167500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"AllowanceForDoubtfulAccountsReceivableCurrent":{"label":"Accounts Receivable, Allowance for Credit Loss, Current","description":"Amount of allowance for credit loss on accounts receivable, classified as current.","units":{"USD":[{"end":"2020-12-31","val":8100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":8400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AllowanceForNotesAndLoansReceivableCurrent":{"label":"Financing Receivable, Allowance for Credit Loss, Current","description":"Amount of allowance for credit loss on financing receivable, classified as current.","units":{"USD":[{"end":"2020-12-31","val":17200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":16900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AmortizationOfFinancingCosts":{"label":"Amortization of Debt Issuance Costs","description":"Amount of amortization expense attributable to debt issuance costs.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":323726518,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":335176570,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":1365100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1367200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":599300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":502200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1":{"label":"Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability","description":"Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-3200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"BusinessCombinationContingentConsiderationLiability":{"label":"Business Combination, Contingent Consideration, Liability","description":"Amount of liability recognized arising from contingent consideration in a business combination.","units":{"USD":[{"end":"2019-12-31","val":16400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2019Q4I"},{"end":"2020-03-31","val":17100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1I"},{"end":"2020-12-31","val":39800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":28000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities":{"label":"Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities","description":"Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.","units":{"USD":[{"end":"2020-12-31","val":19100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":7400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther":{"label":"Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other","description":"Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.","units":{"USD":[{"end":"2020-12-31","val":20700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":20600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CapitalExpendituresIncurredButNotYetPaid":{"label":"Capital Expenditures Incurred but Not yet Paid","description":"Future cash outflow to pay for purchases of fixed assets that have occurred.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":491700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2019Q4I"},{"end":"2020-03-31","val":332900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1I"},{"end":"2020-12-31","val":440100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":329600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect","description":"Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-158800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-110500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2020-12-31","val":346016510,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":374015355,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.00001,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.00001,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":700754910,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1371373770,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":125221900,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":146102070,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":122971900,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":143852070,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ConversionOfStockAmountIssued1":{"label":"Conversion of Stock, Amount Issued","description":"\"The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"\"Part noncash\"\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.\"","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":67600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"DeferredOfferingCosts":{"label":"Deferred Offering Costs","description":"Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.","units":{"USD":[{"end":"2020-12-31","val":1800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":11000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"DepreciationAndAmortization":{"label":"Depreciation, Depletion and Amortization, Nonproduction","description":"The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":12400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":13500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"DepreciationDepletionAndAmortization":{"label":"Depreciation, Depletion and Amortization","description":"The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":12400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":13500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-1.22,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-1.67,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-03-31","val":451500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"FinancingReceivableAllowanceForCreditLosses":{"label":"Financing Receivable, Allowance for Credit Loss","description":"Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.","units":{"USD":[{"end":"2020-12-31","val":17200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":16900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"FinancingReceivableAllowanceForCreditLossesWriteOffs":{"label":"Financing Receivable, Allowance for Credit Loss, Writeoff","description":"Amount of writeoff of financing receivable, charged against allowance for credit loss.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":2200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"FinancingReceivableRecordedInvestmentCurrent":{"label":"Financing Receivable, Not Past Due","description":"Amount of financing receivable not past due.","units":{"USD":[{"end":"2021-03-31","val":43300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"FinancingReceivableRecordedInvestmentPastDue":{"label":"Financing Receivable, Past Due","description":"Amount of financing receivable past due.","units":{"USD":[{"end":"2021-03-31","val":21900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":26500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":92900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"Goodwill":{"label":"Goodwill","description":"Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.","units":{"USD":[{"end":"2020-12-31","val":119800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":154500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments":{"label":"Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-132700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-213100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncomeTaxExpenseBenefit":{"label":"Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsPayableTrade":{"label":"Increase (Decrease) in Accounts Payable, Trade","description":"Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-5400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-3900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsReceivable":{"label":"Increase (Decrease) in Accounts Receivable","description":"The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":8100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncreaseDecreaseInFinanceReceivables":{"label":"Increase (Decrease) in Finance Receivables","description":"The increase (decrease) during the reporting period in outstanding loans including accrued interest.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":60800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncreaseDecreaseInOtherAccruedLiabilities":{"label":"Increase (Decrease) in Other Accrued Liabilities","description":"The increase (decrease) during the reporting period in other expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-4100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":15500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncreaseDecreaseInOtherCurrentAssets":{"label":"Increase (Decrease) in Other Current Assets","description":"Amount of increase (decrease) in current assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":10700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IncreaseDecreaseInOtherNoncurrentAssets":{"label":"Increase (Decrease) in Other Noncurrent Assets","description":"Amount of increase (decrease) in noncurrent assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":4200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":7400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"IntangibleAssetsNetExcludingGoodwill":{"label":"Intangible Assets, Net (Excluding Goodwill)","description":"Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.","units":{"USD":[{"end":"2020-12-31","val":45600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":79200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"InterestExpense":{"label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"InterestPaid":{"label":"Interest Paid, Including Capitalized Interest, Operating and Investing Activities","description":"Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"InvestmentIncomeNonoperating":{"label":"Investment Income, Nonoperating","description":"The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"LettersOfCreditOutstandingAmount":{"label":"Letters of Credit Outstanding, Amount","description":"The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.","units":{"USD":[{"end":"2020-12-31","val":50700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":51700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":741300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":775400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":1365100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1367200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":281900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":306900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"LinesOfCreditCurrent":{"label":"Line of Credit, Current","description":"The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.","units":{"USD":[{"end":"2020-12-31","val":8400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":10200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":6000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":7700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-69200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-167700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-47300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-132700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-212400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1":{"label":"Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)","description":"\"The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"\"Part noncash\"\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.\"","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":13000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"NoninterestBearingDepositLiabilities":{"label":"Noninterest-bearing Deposit Liabilities","description":"The aggregate amount of all domestic and foreign noninterest-bearing deposits liabilities held by the entity.","units":{"USD":[{"end":"2020-12-31","val":46100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":238700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"NotesAndLoansReceivableNetCurrent":{"label":"Financing Receivable, after Allowance for Credit Loss, Current","description":"Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.","units":{"USD":[{"end":"2020-12-31","val":49500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":48300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"NotesReceivableGross":{"label":"Financing Receivable, before Allowance for Credit Loss","description":"Amount, before allowance for credit loss, of financing receivable.","units":{"USD":[{"end":"2021-03-31","val":65200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":754100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1326500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-134200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-212600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"OperatingLeaseLiabilityCurrent":{"label":"Operating Lease, Liability, Current","description":"Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.","units":{"USD":[{"end":"2020-12-31","val":68100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":73300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OperatingLeaseLiabilityNoncurrent":{"label":"Operating Lease, Liability, Noncurrent","description":"Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.","units":{"USD":[{"end":"2020-12-31","val":435900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":441800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OperatingLeaseRightOfUseAsset":{"label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","units":{"USD":[{"end":"2020-12-31","val":426600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":436600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OtherAccruedLiabilitiesCurrent":{"label":"Other Accrued Liabilities, Current","description":"Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":106800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":128200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OtherAssetsCurrent":{"label":"Other Assets, Current","description":"Amount of current assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":54900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":66000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OtherAssetsNoncurrent":{"label":"Other Assets, Noncurrent","description":"Amount of noncurrent assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":32100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":50500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OtherCostAndExpenseOperating":{"label":"Other Cost and Expense, Operating","description":"The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":61100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":70000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"OtherLiabilitiesNoncurrent":{"label":"Other Liabilities, Noncurrent","description":"Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":23500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":26700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"OtherSellingAndMarketingExpense":{"label":"Other Selling and Marketing Expense","description":"Amount of selling and marketing expense classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":106500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":111300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"PaymentForContingentConsiderationLiabilityFinancingActivities":{"label":"Payment for Contingent Consideration Liability, Financing Activities","description":"Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":6300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"PaymentsOfDebtIssuanceCosts":{"label":"Payments of Debt Issuance Costs","description":"The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":2500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"PaymentsToAcquireBusinessesNetOfCashAcquired":{"label":"Payments to Acquire Businesses, Net of Cash Acquired","description":"The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":59200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"PaymentsToAcquirePropertyPlantAndEquipment":{"label":"Payments to Acquire Property, Plant, and Equipment","description":"The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":9300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":10000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ProceedsFromIssuanceOfConvertiblePreferredStock":{"label":"Proceeds from Issuance of Convertible Preferred Stock","description":"The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ProceedsFromLinesOfCredit":{"label":"Proceeds from Lines of Credit","description":"Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":6300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ProceedsFromSaleAndMaturityOfMarketableSecurities":{"label":"Proceeds from Sale and Maturity of Marketable Securities","description":"The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":17300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":14400000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":141700000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":144200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ProvisionForLoanLossesExpensed":{"label":"Financing Receivable, Credit Loss, Expense (Reversal)","description":"Amount of credit loss expense (reversal of expense) for financing receivable.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"RepaymentsOfLinesOfCredit":{"label":"Repayments of Lines of Credit","description":"Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":4500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":38800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":96600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent":{"label":"Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent","description":"Percentage of the total number of positions eliminated as of the balance sheet date since inception of the restructuring plan(s).","units":{"pure":[{"end":"2021-03-31","val":0.15,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"RestructuringCharges":{"label":"Restructuring Charges","description":"Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":6600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"RestructuringReserve":{"label":"Restructuring Reserve","description":"Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-1100900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-1313300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"Revenues":{"label":"Revenues","description":"Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":619900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1113900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"SalesCommissionsAndFees":{"label":"Sales Commissions and Fees","description":"Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":508800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":942200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":11100000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":167500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period","description":"The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":371945,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value","description":"Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":11.8,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period","description":"The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":18088710,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":12.61,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number","description":"The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.","units":{"shares":[{"end":"2020-12-31","val":32556160,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":50272925,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value","description":"Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.","units":{"USD/shares":[{"end":"2020-12-31","val":6.75,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":8.82,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period","description":"The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value","description":"The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted","description":"Net number of non-option equity instruments granted to participants.","units":{"shares":[{"start":"2019-01-01","end":"2019-12-31","val":1061250,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2019"},{"start":"2021-01-01","end":"2021-03-31","val":737560,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-03-31","val":3.47,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value","description":"Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":500000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":79800000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period","description":"The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":401930,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":1888660,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2020-12-31","val":1208000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":780000000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":62827150,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":59603390,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":4.55,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4.86,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number","description":"Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"shares":[{"end":"2021-03-31","val":32491554,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price","description":"Weighted average price at which option holders acquired shares when converting their stock options into shares.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":3.05,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price","description":"Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":6.35,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":11.04,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value","description":"Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.","units":{"USD":[{"end":"2021-03-31","val":470600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-681600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-808600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1I"},{"end":"2020-12-31","val":-862900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-827300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"StockholdersEquityNoteStockSplitConversionRatio1":{"label":"Stockholders' Equity Note, Stock Split, Conversion Ratio","description":"Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.","units":{"pure":[{"end":"2021-03-19","val":10,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1I"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":4710490,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueAcquisitions":{"label":"Stock Issued During Period, Value, Acquisitions","description":"Value of stock issued pursuant to acquisitions during the period.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":4300000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":{"label":"Stock Issued During Period, Value, Conversion of Convertible Securities","description":"The gross value of stock issued during the period upon the conversion of convertible securities.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":67600000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":200000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":9900000,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":108764426,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":126917284,"accn":"0001193125-21-160693","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-13","frame":"CY2021Q1"}]}}}}}